Centrient Pharmaceuticals Netherlands B.V. & ANR v. Sinopharm Weiqida Pharmaceutical Co (Wqd) & ANR

$~14 * IN THE HIGH COURT OF DELHI AT NEW DELHI + CS(COMM) 78/2017, I.A. 1225/2017-Stay, I.A. 16893/2018-O39 R2A, I.A. 17384/2018-O8 R1 r/w O8 R10, I.A. 7627/2019-O6 R17 for amendment of replication by D-1, I.A. 7629/2019-O6 R17 for amendment of written statement by D-1, I.A. 8016/2019-By D-1 for amendment of counter claim, I.A. 9301/2019-O39 R2A CENTRIENT PHARMACEUTICALS NETHERLANDS B.V.

& ANR.

.....Plaintiffs Through:

Ms. Nancy Roy and Ms. Prakriti Varshney, Advs.

versus SINOPHARM WEIQIDA PHARMACEUTICAL CO (WQD) & ANR.

.....Defendants Through:

Ms. Tusha Malhotra and Ms. Tanvi Bhatnagar, Advs.

CORAM:

HON'BLE MR. JUSTICE SAURABH BANERJEE

O R D E R

% 23.04.2025 1.

Since patent no.IN247301 involved in the present proceedings has since expired, learned counsel for the plaintiff seeks to withdraw the present suit. Similarly, learned counsel for the defendants also seeks to withdraw the counter-claim as well.

2.

In view of the aforesaid submissions, both the present suit, as also the counter claim, along with the pending applications therein, are dismissed as withdrawn.

SAURABH BANERJEE, J.

APRIL 23, 2025/R The authenticity of the order can be re-verified from Delhi High Court Order Portal by scanning the QR code shown above. The Order is downloaded from the DHC Server on 25/04/2025 at 17:22:09